Gastro-enteropancreatic Neuroendocrine Tumor

12 clinical trials · Condition

Record	Firm	Date
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET (NCT05050942)	Camurus AB	2021-10-22
Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET (NCT03972488)	Advanced Accelerator Applications	2020-01-08
Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors (NCT03600233)	TaiRx, Inc.	2018-12-15
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (NCT03475953)	Institut Bergonié	2018-05-04
To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) (NCT03220217)	Ipsen	2017-09-26
The Lyon Real World Evidence in Metastatic NeuroEndocrine Tumours (NCT03863106)	Hospices Civils de Lyon	2017-07-15
FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas (NCT03042780)	H. Lee Moffitt Cancer Center and Research Institute	2017-02-01
Pasireotide Treatment for Neuroendocrine Tumor (NCT02779257)	University of Maryland, Baltimore	2016-04-01
The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases (NCT01423734)	Memorial Sloan Kettering Cancer Center	2011-08-23

Every clearance here is in the API, with alerts when new ones post.